156 related articles for article (PubMed ID: 31620667)
21. Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccines.
Khanna R; Burrows SR; Neisig A; Neefjes J; Moss DJ; Silins SL
J Virol; 1997 Oct; 71(10):7429-35. PubMed ID: 9311821
[TBL] [Abstract][Full Text] [Related]
22. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
23. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation.
Hahn YS; Hahn CS; Braciale TJ
Immunol Cell Biol; 1996 Oct; 74(5):394-400. PubMed ID: 8912001
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression.
Zhang Z; Florez S; Gutierrez-Hartmann A; Martin JF; Amendt BA
J Biol Chem; 2010 Nov; 285(45):34718-28. PubMed ID: 20807761
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
26. Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes.
Kono K; Sato E; Naganuma H; Takahashi A; Mimura K; Nukui H; Fujii H
Clin Cancer Res; 2004 Apr; 10(7):2538-44. PubMed ID: 15073134
[TBL] [Abstract][Full Text] [Related]
27. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
28. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
[TBL] [Abstract][Full Text] [Related]
29. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor.
García A; Alvarez CV; Smith RG; Diéguez C
Mol Endocrinol; 2001 Sep; 15(9):1484-95. PubMed ID: 11518797
[TBL] [Abstract][Full Text] [Related]
31. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous localization of Pit-1 protein and gonadotropins on the same cell type in the anterior pituitary glands of the rat.
Vidal S; Román A; Oliveira MC; De La Cruz LF; Moya L
Histochem Cell Biol; 1998 Aug; 110(2):183-8. PubMed ID: 9720991
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
Albert ML; Sauter B; Bhardwaj N
Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
[TBL] [Abstract][Full Text] [Related]
34. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P
Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389
[TBL] [Abstract][Full Text] [Related]
35. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
36. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
[TBL] [Abstract][Full Text] [Related]
37. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.
Kobayashi H; Omiya R; Ruiz M; Huarte E; Sarobe P; Lasarte JJ; Herraiz M; Sangro B; Prieto J; Borras-Cuesta F; Celis E
Clin Cancer Res; 2002 Oct; 8(10):3219-25. PubMed ID: 12374692
[TBL] [Abstract][Full Text] [Related]
38. Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.
Sadegh-Nasseri S; Natarajan S; Chou CL; Hartman IZ; Narayan K; Kim A
Immunol Res; 2010 Jul; 47(1-3):56-64. PubMed ID: 20066513
[TBL] [Abstract][Full Text] [Related]
39. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
40. The HLA system, antigen processing and presentation.
Krensky AM
Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
